Cargando…

The serotonergic system in migraine

Serotonin (5–HT) and serotonin receptors play an important role in migraine pathophysiology. Changes in platelet 5–HT content are not casually related, but they may reflect similar changes at a neuronal level. Seven different classes of serotoninergic receptors are known, nevertheless only 5–HT(2B–2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leone, Massimo, Rigamonti, Andrea, D’Amico, Domenico, Grazzi, Licia, Usai, Susanna, Bussone, Gennaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2001
Materias:	Migraine and Pathophysiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3451809/ http://dx.doi.org/10.1007/s101940170008

Ejemplares similares

Disability and migraine: MIDAS
por: D’Amico, Domenico, et al.
Publicado: (2001)

Disability in migraine patients: Italian experience
por: Bussone, Gennaro, et al.
Publicado: (2001)

Role of dopaminergic system in migraine
por: Cherchi, Alessandra, et al.
Publicado: (2001)

GABA and glutamate in migraine
por: D’Andrea, Giovanni, et al.
Publicado: (2001)

Platelets in migraine
por: Sarchielli, Paola, et al.
Publicado: (2001)

Neurophysiology of migraine
por: Sandrini, Giorgio, et al.
Publicado: (2001)

The genetics of migraine
por: Montagna, Pasquale
Publicado: (2001)

Expression of NOS–2, COX–2 and Th1/Th2 cytokines in migraine
por: Martelletti, Paolo, et al.
Publicado: (2001)

Do changes of ANS in migraine subjects play a pathogenetic role?
por: Cortelli, Pietro, et al.
Publicado: (2001)

An Italian pilot study on the use of the migraine disability assessment questionnaire
por: D'Amico, Domenico, et al.
Publicado: (2000)

Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan
por: Allais, Gianni, et al.
Publicado: (2010)

Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability
por: D’Amico, Domenico, et al.
Publicado: (2006)

Migraine and risk of stroke
por: Øie, Lise R, et al.
Publicado: (2020)

Menstrual migraine
por: Moschiano, Franca, et al.
Publicado: (2001)

Diagnostic and therapeutic aspects of hemiplegic migraine
por: Di Stefano, Vincenzo, et al.
Publicado: (2020)

Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety
por: Blumenfeld, Andrew M, et al.
Publicado: (2019)

Headache-related health resource utilisation in chronic and episodic migraine across six countries
por: Sanderson, Joanna C, et al.
Publicado: (2013)

Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
por: Silberstein, Stephen D, et al.
Publicado: (2015)

Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials
por: Reuter, Uwe, et al.
Publicado: (2019)

Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
por: Goadsby, Peter J, et al.
Publicado: (2019)

Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
por: Gonçalves, Andre Leite, et al.
Publicado: (2016)

Gingkolide B as migraine preventive treatment in young age: results at 1-year follow-up
por: Usai, Susanna, et al.
Publicado: (2011)

Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study
por: Lanteri-Minet, Michel, et al.
Publicado: (2021)

Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY study
por: Ferrari, Michel Dominique, et al.
Publicado: (2022)

An innovative approach for migraine prevention in young age: a preliminary study
por: Usai, Susanna, et al.
Publicado: (2010)

Epidemiology of migraine
por: Manzoni, Gian Camillo, et al.
Publicado: (2001)

Socio–economic costs of migraine
por: Cerbo, Rosanna, et al.
Publicado: (2001)

Health–related quality of life (HRQOL) and migraine
por: Apolone, Giovanni, et al.
Publicado: (2001)

Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies
por: Allais, Gianni, et al.
Publicado: (2012)

Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan
por: Newman, L C, et al.
Publicado: (2008)

Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2015)

Localised increase in regional cerebral perfusion in patients with visual snow syndrome: a pseudo-continuous arterial spin labelling study
por: Puledda, Francesca, et al.
Publicado: (2021)

Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study
por: Tullo, Vincenzo, et al.
Publicado: (2012)

Disability and migraine: recent outcomes using an Italian version of MIDAS
por: D'Amico, Domenico, et al.
Publicado: (2003)

Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
por: Tullo, Vincenzo, et al.
Publicado: (2010)

Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, Gianni, et al.
Publicado: (2014)

Disability, ICF biopsychosocial model and burden of migraine
por: Leonardi, Matilde, et al.
Publicado: (2015)

Magnetic resonance spectroscopy studies in migraine
por: Nikolova, Simona, et al.
Publicado: (2022)

Disability and quality of life in patients with different forms of migraine
por: D'Amico, Domenico, et al.
Publicado: (2015)

Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans
por: Franconi, Flavia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_blu015q0g4uod6ahmn685lc4sm